- Home
- ICUCW vs CENX Comparison
ICUCW vs CENX Comparison
Compare ICUCW & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUCW
- CENX
- Stock Information
- Founded
- ICUCW N/A
- CENX 1995
- Country
- ICUCW United States
- CENX United States
- Employees
- ICUCW 19
- CENX N/A
- Industry
- ICUCW Biotechnology: Pharmaceutical Preparations
- CENX Aluminum
- Sector
- ICUCW Health Care
- CENX Industrials
- Exchange
- ICUCW Nasdaq
- CENX Nasdaq
- Market Cap
- ICUCW N/A
- CENX 1.7B
- IPO Year
- ICUCW 2021
- CENX 1996
- Fundamental
- Price
- ICUCW $0.03
- CENX $20.76
- Analyst Decision
- ICUCW
- CENX Strong Buy
- Analyst Count
- ICUCW 0
- CENX 3
- Target Price
- ICUCW N/A
- CENX $23.00
- AVG Volume (30 Days)
- ICUCW N/A
- CENX 1.4M
- Earning Date
- ICUCW N/A
- CENX 08-07-2025
- Dividend Yield
- ICUCW N/A
- CENX N/A
- EPS Growth
- ICUCW N/A
- CENX N/A
- EPS
- ICUCW N/A
- CENX 1.22
- Revenue
- ICUCW N/A
- CENX $2,364,700,000.00
- Revenue This Year
- ICUCW N/A
- CENX $7.19
- Revenue Next Year
- ICUCW N/A
- CENX $3.99
- P/E Ratio
- ICUCW N/A
- CENX $16.96
- Revenue Growth
- ICUCW N/A
- CENX 11.41
- 52 Week Low
- ICUCW N/A
- CENX $11.40
- 52 Week High
- ICUCW N/A
- CENX $25.39
- Technical
- Relative Strength Index (RSI)
- ICUCW N/A
- CENX 68.86
- Support Level
- ICUCW N/A
- CENX $18.00
- Resistance Level
- ICUCW N/A
- CENX $19.32
- Average True Range (ATR)
- ICUCW 0.00
- CENX 0.81
- MACD
- ICUCW 0.00
- CENX 0.17
- Stochastic Oscillator
- ICUCW 0.00
- CENX 96.24
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.